학술논문
2018 annual dialysis data report of the JSDT Renal Data Registry: patients with hepatitis
Document Type
Survey
Author
Nitta, Kosaku; Nakai, Shigeru; Masakane, Ikuto; Hanafusa, Norio; Goto, Shunsuke; Taniguchi, Masatomo; Hasegawa, Takeshi; Wada, Atsushi; Hamano, Takayuki; Hoshino, Junichi; Joki, Nobuhiko; Yamamoto, Keichi; Miura, Kenichiro; Abe, Masanori; Nakamoto, Hidetomo; Maeno, Kazuyuki; Kawata, Tetsuya; Oyama, Chikara; Seino, Koji; Sato, Toshinobu; Sato, Shigeru; Ito, Minoru; Kazama, Junichiro; Ueda, Atsushi; Saito, Osamu; Ando, Tetsuo; Ogawa, Tomonari; Kumagai, Hiroo; Terawaki, Hiroyuki; Ando, Ryoichi; Abe, Masaki; Kashiwagi, Tetsuya; Hamada, Chieko; Shibagaki, Yugo; Hirawa, Nobuhito; Shimada, Hisaki; Ishida, Yoichi; Yokoyama, Hitoshi; Miyazaki, Ryoichi; Fukasawa, Mizuya; Kamijyo, Yuji; Matsuoka, Teppei; Kato, Akihiko; Mori, Noriko; Ito, Yasuhiko; Kasuga, Hirotake; Koyabu, Sukenari; Arimura, Tetsuro; Hashimoto, Tetsuya; Inaba, Masaaki; Hayashi, Terumasa; Yamakawa, Tomoyuki; Nishi, Shinichi; Fujimori, Akira; Yoneda, Tatsuo; Negi, Shigeo; Nakaoka, Akihisa; Ito, Takafumi; Sugiyama, Hitoshi; Masaki, Takao; Nitta, Yutaka; Okada, Kazuyoshi; Yamanaka, Masahito; Kan, Masaharu; Ota, Kazumichi; Tamura, Masahito; Mitsuiki, Koji; Ikeda, Yuji; Nishikido, Masaharu; Miyata, Akira; Tomo, Tadashi; Fujimoto, Shoichi; Nosaki, Tsuyoshi; Oshiro, Yoshinori
Source
Renal Replacement Therapy. May 10, 2021, Vol. 7 Issue 1
Subject
Language
English
Abstract
Author(s): Kosaku Nitta[sup.1], Shigeru Nakai[sup.1,2], Ikuto Masakane[sup.1], Norio Hanafusa[sup.1], Shunsuke Goto[sup.1], Masatomo Taniguchi[sup.1], Takeshi Hasegawa[sup.1], Atsushi Wada[sup.1], Takayuki Hamano[sup.1], Junichi Hoshino[sup.1], Nobuhiko Joki[sup.1], Keichi Yamamoto[sup.1], Kenichiro Miura[sup.1], Masanori Abe[sup.1], Hidetomo [...]
According to the annual survey of the Japanese Society for Dialysis Therapy Renal Data Registry (JRDR) conducted at the end of 2018, a total of 339,841 patients were receiving dialysis (hereinafter, dialysis patients) in Japan. This survey included an investigation of individual test results for hepatitis B surface antigen (HBsAg), hepatitis C virus (HCV) antibody (HCV-Ab), HCV-RNA, and serum alanine aminotransferase (ALT) (glutamic pyruvic transaminase [GPT]). The survey revealed that among dialysis patients in Japan, the prevalence of HBsAg positivity was 1.38% and the prevalence of HCV-Ab positivity was 4.7% at the end of 2018, both of which were markedly lower than the corresponding rates documented in 2007 (9.8% and 4.7%, respectively). The proportion of HCV-RNA-positive patients among all HCV-Ab-positive patients was 37.5%, which was also markedly lower than the percentage recorded in 2007 (64.0%). The prevalence of HBsAg positivity tended to increase as the dialysis vintage increased. The prevalence of HCV-Ab positivity was also not correlated with the dialysis vintage during the first 30 years of dialysis; however, it tended to increase as the dialysis vintage increased beyond the 30th year. Trial registration University hospital Medical Information Network (UMIN) Clinical Trials Registry, UMIN000018641. The JRDR was approved by the ethics committee of the JSDT (approval number 1-3) and was registered on August 8, 2015 (accessed June 2, 2020). Keywords: Dialysis, Registry, Hepatitis, Prevalence
According to the annual survey of the Japanese Society for Dialysis Therapy Renal Data Registry (JRDR) conducted at the end of 2018, a total of 339,841 patients were receiving dialysis (hereinafter, dialysis patients) in Japan. This survey included an investigation of individual test results for hepatitis B surface antigen (HBsAg), hepatitis C virus (HCV) antibody (HCV-Ab), HCV-RNA, and serum alanine aminotransferase (ALT) (glutamic pyruvic transaminase [GPT]). The survey revealed that among dialysis patients in Japan, the prevalence of HBsAg positivity was 1.38% and the prevalence of HCV-Ab positivity was 4.7% at the end of 2018, both of which were markedly lower than the corresponding rates documented in 2007 (9.8% and 4.7%, respectively). The proportion of HCV-RNA-positive patients among all HCV-Ab-positive patients was 37.5%, which was also markedly lower than the percentage recorded in 2007 (64.0%). The prevalence of HBsAg positivity tended to increase as the dialysis vintage increased. The prevalence of HCV-Ab positivity was also not correlated with the dialysis vintage during the first 30 years of dialysis; however, it tended to increase as the dialysis vintage increased beyond the 30th year. Trial registration University hospital Medical Information Network (UMIN) Clinical Trials Registry, UMIN000018641. The JRDR was approved by the ethics committee of the JSDT (approval number 1-3) and was registered on August 8, 2015 (accessed June 2, 2020). Keywords: Dialysis, Registry, Hepatitis, Prevalence